Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414546 | SCV000491302 | pathogenic | not provided | 2016-12-06 | criteria provided, single submitter | clinical testing | The E774K variant in the BICD2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. However, a missense variant at this same codon (E774G) has been reported as a de novo variant in an individual with spinal muscular atrophy (Peeters et al., 2013). The E774K variant is not observed in large population cohorts (Lek et al., 2016). The E774K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. We interpret E774K as a pathogenic variant |
OMIM | RCV000049277 | SCV000077534 | pathogenic | Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures | 2013-06-06 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium Ii, |
RCV000049277 | SCV004011900 | uncertain significance | Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures | 2016-01-06 | no assertion criteria provided | literature only |